{"id":6123,"date":"2023-05-10T15:28:36","date_gmt":"2023-05-10T13:28:36","guid":{"rendered":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/?p=6123"},"modified":"2023-05-10T15:28:36","modified_gmt":"2023-05-10T13:28:36","slug":"comunicados-proceso-descuelgue-y-modificacion","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicados-proceso-descuelgue-y-modificacion\/","title":{"rendered":"Comunicados Proceso Descuelgue y Modificaci\u00f3n"},"content":{"rendered":"\n<h2 class=\"gb-headline gb-headline-30abdf10 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-1\/\" class=\"ek-link\">Comunicado &#8211; 1<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-78c1d6f5 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-2\/\" class=\"ek-link\">Comunicado &#8211; 2<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-50843cd2 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-3\/\" class=\"ek-link\">Comunicado &#8211; 3<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-67cabda5 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-4\/\" class=\"ek-link\">Comunicado &#8211; 4<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-c524afcb gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-5\/\" class=\"ek-link\">Comunicado &#8211; 5<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-be9e06b2 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-6\/\" class=\"ek-link\">Comunicado &#8211; 6<\/a><\/h2>\n\n\n\n<h2 class=\"gb-headline gb-headline-9d8492b4 gb-headline-text\"><a href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/comunicado-7\/\" class=\"ek-link\">Comunicado &#8211; 7<\/a><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Comunicado &#8211; 1 Comunicado &#8211; 2 Comunicado &#8211; 3 Comunicado &#8211; 4 Comunicado &#8211; 5 Comunicado &#8211; 6 Comunicado &#8211; 7<\/p>\n","protected":false},"author":59,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-6123","post","type-post","status-publish","format-standard","hentry","category-publicacion-web","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=6123"}],"version-history":[{"count":1,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6123\/revisions"}],"predecessor-version":[{"id":6124,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6123\/revisions\/6124"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=6123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=6123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=6123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}